3464 results for «2022»
3464 results
My worst nightmare in TAVI
Listen to our experts share their most nightmarish TAVI cases and follow the debate around their treatments. For instance, would you make the same choices when faced with a 76-year-old female patient diagnosed as severe AS, transferred for SAVR/TAVI, who got a new Abif and cardiogenic...
PCR Tokyo Valves 2023 Closing Ceremony
19 Feb 2023 – From PCR Tokyo Valves 2023
This closing ceremony of the 2023 edition of the PCR Tokyo Valves is the occasion to unveil the results of the best abstract and best case competitions and to congratulate the finalists. It is also the moment to take stock of this excellent edition, to thank...
TAVI in small annulus and coronary artery disease - Session with LIVE case
19 Feb 2023 – From PCR Tokyo Valves 2023
Watch the complex case of an 84-year-old woman with hypertension, type 2 diabetes and coronary artery disease who presented with worsening NYHA class II-III exertional dyspnoea, but no angina, and find out how she was treated LIVE.
The optimal first valve choice for all patients with aortic stenosis
18 Feb 2023 – From PCR Tokyo Valves 2023
How have advances in TAVI impacted the lifetime journey of patients with aortic stenosis? Join this panel of experts as they discuss the importance of optimizing the first procedure and the key issues regarding treatment options in patients with bioprosthetic valve deterioration of transcatheter heart valve.
How to optimise the lifetime management of TAVI patients with long-life expectancy?
18 Feb 2023 – From PCR Tokyo Valves 2023
This session addresses three essential elements of a successful TAVI procedure: the impact of valve design on long-term durability, how to mitigate the risk of paravalvular leakage, and the importance of the possibility for coronary access after TAVI.
Remaining unmet needs and strategies in TAVI
19 Feb 2023 – From PCR Tokyo Valves 2023
This session focuses on valve design and durability performance in TAVI for patients with aortic stenosis, and the way it impacts future patient outcomes.
Mitral and tricuspid patients are different from the TAVI population - Impact on clinical care
28 Nov 2022 – From PCR London Valves 2022
Consult this session to learn more about the different needs of mitral and tricuspid patients, to appreciate what optimal medical therapy really means and to improve your knowledge of the anticoagulant requirements for different patient populations.
Complex CTOs in CHIP
14 Dec 2022 – From GulfPCR-GIM 2022
Watch this session if you want to understand when and how protected PCI with mechanical support in CHIP is needed. You'll also learn about complex CTO PCI treatment in both antegrade and retrograde approaches, and plaque debulking techniques in severe calcified lesions.
Optimal management of a patient with calcified lesions - Session with LIVE case
15 Dec 2022 – From GulfPCR-GIM 2022
Watch the case of an 87-year-old male patient with DM, HTN, and hyperlipidemia, who suffered ACS six weeks ago, whose culprit lesions were treated in the RCA and LCX, and who was incidentally readmitted for LAD PCI, and find out how he was treated LIVE.
Rethinking PCI in left main: OCT-guided optimisation
17 May 2023 – From EuroPCR 2023
Discover the transformative role of optical coherence tomography (OCT) in optimizing left main percutaneous coronary intervention (PCI) in this session. Gain insights into how OCT can guide the step-by-step process of left main PCI to achieve optimal results, and explore the crucial parameters of procedural outcome,...
Innovations in device-based treatment for hypertension
17 May 2023 – From EuroPCR 2023
Join this session to explore the latest innovations in device-based treatment for hypertension. Gain a comprehensive understanding of the evidence supporting the efficacy, durability, and safety of radiofrequency renal denervation, learn from renowned experts about the renal denervation procedure and receive valuable insights on patient selection...
Selecting the right first valve to secure lifetime management
17 May 2023 – From EuroPCR 2023
The treatment of young and less at-risk patients clearly shows that their age, life expectancy and risk factors are essential parameters to be taken into account in the choice of TAVI and therefore it is essential to think about future coronary access after TAVI. Watch the...
Complex coronary artery disease: can stents and DCB be complementary?
16 May 2023 – From EuroPCR 2023
DES and DCB, can these two technologies be complementary for the treatment of the same patient? What are the advantages and how to proceed? You will know everything by watching this presentation based on concrete cases.
The importance of optimal vascular access and closure in TAVI patients
16 May 2023 – From EuroPCR 2023
In this session, a panel of experts focus on access and closure, a crucial aspect of TAVI. This discussion offers valuable insights into effective planning and achieving access for a TAVI procedure using echo guidance. It provides a step-by-step guide on closing a TAVI procedure using...
Third generation OCT (HF-OCT): no more limits to the routine clinical use of intravascular imaging
17 May 2023 – From EuroPCR 2023
Imaging is critical to strategy management. If you want to get a sense of the contributions of HF-OCT in clinical routine, listen to the speakers talk about their real-world experience and learn from their case presentations.
From proof to practice - Treating hypertension with ultrasound renal denervation
16 May 2023 – From EuroPCR 2023
Renal denervation: what are the latest clinical evidences and benefits? How to select the good candidate? How to establish a dedicated centre? All the anwers to these questions and more in this video.
Insights into coronary physiology: pressure microcatheter for clinical decision-making and PCI optimisation
17 May 2023 – From EuroPCR 2023
In this session, analyze the case of a 71-year-old current smoker man with HTN and stable angina CCS II to understand how coronary physiology helps predict what is going to happen after PCI.
Robotic PCI: real-life experience with a new robotic platform
16 May 2023 – From EuroPCR 2023
The current problems in interventional cardiology have been the same for years: exposure to X-rays, or orthopaedic injuries to operators after decades in the cathlab. The solution to these problems could lie in robotics and the increasing use of artificial intelligence in practice. Follow this session...
Cutting-edge technologies: clinical updates on TES, BRS, TAVR and LAA closure
17 May 2023 – From EuroPCR 2023
Watch this session to find out more about the three-year outcomes of the FUTURE-II Trial, the TARGET clinical trial roadmap, the TARGET IV NA Trial update, the twelve-month outcomes of the SAVE PROTECT Trial, and the quantitative aortographic assessment of regurgitation in patients treated with VitaFlow.
Lifetime management - Tailoring treatment options to secure future possibilities
16 May 2023 – From EuroPCR 2023
Check out this session if you want to better understand the importance of paravalvular leaks and conduction disorders after TAVI on long-term outcomes. You will also learn about the latest data on the lifetime management of patients with aortic stenosis, and value the importance of TAVI...
